Cargando…
305 Leveraging multi-timepoint blood samples to characterize cancer-associated mutations in the blood over time
OBJECTIVES/GOALS: Clonal hematopoiesis of indeterminate potential (CHIP) is a common age-related condition that confers an increased risk of blood cancer, cardiovascular disease, and overall mortality. Larger proportions of blood cells with the CHIP mutation (clones) lead to worse outcomes. The goal...
Autores principales: | Mack, Taralynn, Von Beck, Kelly, Silver, Alexander, Savona, Michael, Vanderbilt, Alexander Bick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129680/ http://dx.doi.org/10.1017/cts.2023.358 |
Ejemplares similares
-
Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
por: Park, Elyse R, et al.
Publicado: (2022) -
Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
por: Larkin, James R., et al.
Publicado: (2022) -
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
por: Chen, Xiaoji, et al.
Publicado: (2021) -
38081 A Whole Blood Signature of Neutrophil Expression and Adaptive Immune Downregulation Characterizes Sepsis Mortality
por: Giannini, H.M., et al.
Publicado: (2021) -
Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial—First progress report
por: Chori, Babangida S., et al.
Publicado: (2023)